+ All Categories
Home > Documents > alergi.ppt

alergi.ppt

Date post: 09-Nov-2014
Category:
Upload: oyien14
View: 110 times
Download: 2 times
Share this document with a friend
Popular Tags:
35
The most prevalent of type I allergic dis. The symptoms and signs caused by mediators : vessels, glands and nerves. Classified as inflammatory disease. ALLERGIC RHINITIS :
Transcript
Page 1: alergi.ppt

• The most prevalent of type I allergic dis.

• The symptoms and signs caused by

mediators :

vessels, glands and nerves.

• Classified as inflammatory disease.

ALLERGIC RHINITIS :

Page 2: alergi.ppt

ALLERGIC RHINITIS :

• Sign & symptoms :– Itching nose– Sneezing– Rhinorrhea– Nasal obstruction

Allergic salute

Page 3: alergi.ppt

EPIDEMIOLOGY• Prevalence in ISAAC (Asher 1995) :

0.8 – 14.95 % in 6-7 years old 1.4 – 39.7 % in 13 – 14 years old

• Low pervalence : Indonesia, Georgia, Greece • Semarang (2002) ISAAC phase 3, RA : 18,6% • High pervalence : Australia, UK and Latin America• In adults : no equivalent to ISAAC study • National survey : 5.9 % France and 29 % UK

Page 4: alergi.ppt

WHO Classification of Allergic rhinitis

1. INTERMITTENT – Less than 4 days a week, or– Less than 4 weeks

2. PERSISTENT– More than 4 days a week, and– More than 4 weeks

Page 5: alergi.ppt

SEVERITY OF THE DISEASE

1. MILD – means no one of the following items are present– Sleep disturbance– Impairment of daily activities / sport– Impairment of school / work– Troublesome symptoms

2. MODERATE – SEVERE, when one or more of the symptoms are present

Page 6: alergi.ppt

( Adapted from Creticos, 1998 )

-

MHC

Fragment

Th2

PATOFISIOLOGI

CHRONIC

INFLAMMATION

(LATE PHASE)

RhinoreaSneezing

Congestion

ACUT

E

SYMTOMS

Rhinorea

Sneezing

Congestion

Basic proteins

LtsCytokines

HISTAMINELts

Cytokines

HistamineTriptasePGD2LTsCytokines

E A R L Y P H A S E

IgE-bearing B-cellsIgE-bearing B-cells

IgE antibody IgE antibody IgE IgE

IgE IgE

Mastosit

3

LATE P H A S E

(I)

(II)

Page 7: alergi.ppt

MECHANISMS OF Allergic RHINITIS

Mast cell

HistamineLeukotrienesProstaglandin'sBradykinin,PAF

Itch, sneezingWatery dischargeNasal congestion

allergen

Th2 cell

B cell

eosinophils Nasal blockadeLoss of smellNasal hyperreactivity

IL4

IgE

IL 3, 5, GMCSF

Immediate rhinitis symptoms

Chronic ongoing rhinitis

Page 8: alergi.ppt

MAST CELL DEGRANULATION

Histamine, Heparin, Tryptase, TNF , TGF , IL 3, 4, 5, 13

Newly formed mediators

PLA2 AA + PAF

C.O 5 L.O

PGD2 LTC4 LTB

LTD4

LTE4

Y

Yallergen

Preformed mediators

Y Y

Y

Page 9: alergi.ppt

HISTAMINE

HH11-R-R

DEGRADATION( histamine methyl transferase)

CNS Endothelium(Vascular Permeability)

Nociceptive Nerves

• Itch.• Systemic Reflexes Sneeze Allergic Salute

Serous/Mucous Secretion• Parasympathic Reflexes Glandular Exocytosis

HISTAMINE EFFECTS

Vascular wall

Vasodilatation

Page 10: alergi.ppt

Diagram of DIAGNOSTIC PROCEDURES (1)

patients with AR symptoms ( history of illness + physical exam.)

skin prick test

(+)

AR with complications / concomitant dis

AR without complication

eosinophil on nasal cytology

(+)

allergic Rhinitis ?

(-)

non allergic rhinitis

NARES

(-)

Page 11: alergi.ppt

Diagnostic Procedures (2)

1. Anamnesis– Chief complain :

1. Itching nose

2. Sneezing : morning >>

3. Serous nasal secretion

4. Nasal obstruction at night

Page 12: alergi.ppt

Diagnostic Procedures (3)

1. Anamnesis

– The symptoms was environment related

– History of other allergic manifestation of patients and other allergic familial manifestations

– Duration of illness, severity of the disease and the respond of the previous treatment

Page 13: alergi.ppt

Diagnostic Procedures

2. Physical examination Should be performed with appropriate lighting

and use of nasal speculum

normal oedema

Page 14: alergi.ppt

Diagnostic Procedures (5)2. Physical examination

– Including : 1. Nasal passage ways

2. Nasal mucosa

3. Turbinates

4. Secretion

5. Septum

6. Polyps ?

7. Sinusitis ?

Page 15: alergi.ppt

Diagnostic Procedures (6)

3. Nasal cytology

– Large number of eosinophils may aid to differentiate AR & NARES from other Rhinitis

– No consensus to routinely performed for evaluation of rhinitis

Page 16: alergi.ppt

Diagnostic Procedures (7)

4. Total serum Ig E

– Neither very sensitive nor very specific

– 35 – 50 % AR Normal Ig E levels

– Poor correlation with symptom and skin testing result

Page 17: alergi.ppt

Diagnostic Procedures (8)

5. Nasal provocation testing

– Based on a history of AR symptoms provoked by allergen exposure and confirmed by skin testing

– It may be required for confirmation of sensitivity to allergen in the work place

Page 18: alergi.ppt

Diagnostic Procedures (9)

6. Special diagnostic techniques

– Upper airway endoscopy / Rhinomanometry

– Standard radiographs

– CT

– MRI

Page 19: alergi.ppt

Diagnostic Procedures (10)7. Testing for specific Ig E,

important for :

– Determining whether patient has allergic rhinitis

– Identifying specific allergen for avoidance measurement and allergen immunotherapy

Page 20: alergi.ppt

Diagnostic Procedures (11)

8. Skin testing to allergen : – Simple– Ease– Rapid performance– Low cost– High sensitivity / spesificity ( Prick test )

Page 21: alergi.ppt

Allergy skin prick testing

Skin prick test :

positive result

wheal > 3mm diameter

Page 22: alergi.ppt

A R and other diseases

Allergic Rhinitis

O M E

Nasal polyp

Sinusitis

U R T infection

Bronkhial

asthma

Page 23: alergi.ppt

Comorbidity AR and Sinusitis

• US : sinusitis 30 Mill / year (1989 ) sinusitis : 25 – 30 % AR

non sinusitis : 14 – 17 % AR

• Sinusitis ( dx CT ) Newman at all 1994 :– AR : 78 %

– Asthma : 71 %

Page 24: alergi.ppt

Differential diagnosis of RA

Non – allergic rhinitis :• Infectious : bacterial, viral, fungal

• Drug induced : aspirin & other medications

• Occupational rhinitis (allergy & non allergy)

• Hormonal : puberty, pregnancy, menstruation

and hormonal disorders

• Other causes : foods, irritants, emotions,

NARES

• Atrophic Rhinitis

• Idiopatic

Page 25: alergi.ppt

Management of AR

Objectives :

– relieving symptoms for improving QOL

– to avoid triggering factor

– to avoid / to treat complication

– to change the natural history

Page 26: alergi.ppt

Allergen elimination

EDUCATION

– Explain what is allergic rhinitis / reaction

– Explain the meaning of pos. allergic skin test

– Confirm whether there is correlation between allergen contact & rhinitis attack

– Explain how to do allergen avoidance

– Encourage to avoid the allergens

Page 27: alergi.ppt

Globally important allergens

mites

pollen

mites sources

weed cockroaches

pets : dogs

Page 28: alergi.ppt

• Pharmacological treatment

1. ANTIHISTAMINE– First line– Consider new antihistamine since :• Long acting more practical• No sedating normal daily activity• No / less cardiac effect• Broad spectrum effects

– Except :• Patient doesn’t mind sedation effect• It is not available• Can not be afforded Classic antihistamine can be considered

Page 29: alergi.ppt

2. NASAL DECONGESTANT• Indicated in patient with prominent nasal

obstruction complaint• As addition / combination with A H

Long term treatment– Systemic nasal decongestant, be careful

in hypertension cases and glaucoma.– Topical : rebound effect

Page 30: alergi.ppt

3. INTRANASAL CORTICOSTEROID

– Long term treatment safer than systemic application

– Effective to control AR symptoms Note :– Patients should be well informed how to

use – Symptoms relieve is not directly achieved – In some places it is unavailable

Page 31: alergi.ppt

• Allergen Specific Immunotherapy ( ASIT )

ASIT : effective for treating allergic rhinitis

Recommended in patients with :

– severe symptoms

– failed by pharmacological treatment

– positive correlation skin test & history

– agree & well informed about duration, schedule of injection & expected results

Page 32: alergi.ppt

Updated ARIA recommendation

(Allergy Supl 86: 63 2008)

Intermittent symptoms Persistent symptoms

MildNot in preferred

orderOral H1 blocker

or intranasaland/or

decongestant

Moderate-severe Mild

Not in preferred orderOral/ intranasal H1 blocker

And/ or decongestantor intranasal CS

In persistent ARReview after 2-4 weeks

If failure, step upIf improved: continue for

1 mo

Moderate- severe

In preferred orderIntra nasal CS, H1 blocker

Review after 2-4 weeks

improved failure

Step-down& continue >

1mo Review : Dx, complianceInfection or other causes

Increase intranasal CS

doses

Rhhinorrheaadd ipratropium

Blockade, add decongestant or

Oral CS

Failure: referred

Consider specific immunotherapy

Diagnosis of Allergic rhinitis Check for asthma

Page 33: alergi.ppt

Intermittent AR : Adults & children

Is therapy needed ? If yes

Non-pharmacological therapyAllergen avoidance measure

Is pharmacotherapy needed ? If yes

Mild disease Moderate disease Severe disease

Oral/nasal AH or cromon

Nasal corticosteroids

Nasal CS & oral/ nasal AH

Add further symptomatic treatment

OrShort course oral CS

Or Consider IT

If inadequatecontrol

Page 34: alergi.ppt

Persistent AR : Adults Is therapy needed ? If yes

Non-pharmacological therapyAllergen avoidance measure

Environment control

Is pharmacotherapy needed ? If yes

Mild disease Moderate disease Severe disease

Oral/ nasal antihistamine

Nasal corticosteroids

Nasal CS & Oral antihistamine

If inadequatecontrol If resistent

Page 35: alergi.ppt

If resistent

Nasal blockage

RhinorrheaAntihistamine and

Oral / nasal decongestant

OrShort course oral

steroid

Nasal ipratropium bromide

If persistent

ConsiderImmunotherapy

If inadequate control

Further examination & consider immunotherapy

Or Surgical turbinate reduction


Recommended